Tracking the rollout of the COVID-19 vaccines as the United States emerges from the pandemic.
Se supone que las vacunas contra el coronavirus son gratuitas y están disponibles para todos en Estados Unidos, independientemente de su seguro o de su situación migratoria. Para algunos, no ha sido así.
Vaccinations for the coronavirus are supposed to be free and available to all Americans regardless of insurance or immigration status. For some, that isn’t how it has been playing out. Here are common false barriers to look out for.
El desarrollo y la distribución de una vacuna afectará a todos los habitantes del planeta. Ayúdenos a identificar historias importantes para poder contarlas.
People eligible for the coronavirus vaccine tell us they are running up against barriers that are designed into the very systems meant to serve those most at risk of dying of the disease. We plan to continue tracking these roadblocks.
President Biden has promised enough doses for all American adults by this summer. There’s not much even the Defense Production Act can do to deliver doses before then.
For this to happen by the start of the next school year, trials need to prove the vaccine is safe and effective in children. Experts say manufacturers aren’t moving quickly enough, and that this is important for achieving herd immunity and stopping the spread of variants.
Governors continue to open indoor dining and other activities before vaccinations become widespread. Experts warn this could create superspreading playgrounds for dangerous variants and squander our best shot at getting the pandemic under control.
The CDC says health facilities should report unused and spoiled COVID-19 vaccines, but many are failing to do so. At a time when there aren’t enough shots to meet demand, significant numbers may be going in the trash.
States are struggling to plan their vaccination programs with just one week’s notice for how many doses they’ll receive from the federal government. The incoming Biden administration is deciding what to do with this dysfunctional system.
States and the federal government also don’t reliably collect data so we won’t have a good idea of whether the vaccine is reaching these critical populations.
A review of state distribution plans reveals that officials don’t know how they’ll deal with the difficult storage and transport requirements of Pfizer’s vaccine, especially in the rural areas currently seeing a spike in infections.